United States · FDA National Drug Code directory

Ezetimibe

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 51660-200_12e7e79e-85d0-0c5d-e063-6394a90a8b78
Product NDC: 51660-200
Form: TABLET
Composition / generic term: Ezetimibe
Labeler: Ohm Laboratories Inc.
Marketing category: ANDA
Marketing start / end (source format): 20170612
Source listing expiry: 20261231

Source-listed ingredients

EZETIMIBE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

500 TABLET in 1 BOTTLE (51660-200-05) · 51660-200-05
30 TABLET in 1 BOTTLE (51660-200-30) · 51660-200-30
90 TABLET in 1 BOTTLE (51660-200-90) · 51660-200-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →